NASDAQ:BBH VanEck Biotech ETF (BBH) Price, Holdings, & News → 348 million Americans lives to END as we know it? (From The Oxford Club) (Ad) Free BBH Stock Alerts $168.54 -0.11 (-0.07%) (As of 05/16/2024 ET) Add Compare Share Share Today's Range$167.26▼$168.7250-Day Range$151.99▼$168.6552-Week Range$142.51▼$171.04Volume4,194 shsAverage Volume7,933 shsMarket Capitalization$446.63 millionAssets Under Management$442.06 millionDividend Yield0.42%Net Expense Ratio0.35% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media Get VanEck Biotech ETF alerts: Email Address About VanEck Biotech ETF (NASDAQ:BBH)The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.Read More BBH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BBH ETF News HeadlinesMay 16 at 5:36 AM | americanbankingnews.comVanEck Biotech ETF (NASDAQ:BBH) Short Interest Down 16.0% in AprilMarch 29, 2024 | benzinga.comFuture-Proof Your Portfolio: Learn From ETF Expert Jan Van Eck In NYCMarch 22, 2024 | seekingalpha.comGNOM: Genomics Still Waiting For Its 'ChatGPT' MomentJanuary 30, 2024 | msn.comVanEck CEO Says Cryptos Deserve A Place In Everyone's PortfolioDecember 19, 2023 | msn.comVanEck Vectors Biotech ETF declares annual distribution of $0.7127December 9, 2023 | seekingalpha.comBBH: A Solid Way To Play A Comeback In BiotechOctober 24, 2023 | investing.comBBH ETF Stock Price HistorySeptember 13, 2023 | msn.comBBH: Our Favorite Biotech ETF Can Keep OutperformingSee More Headlines Receive BBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Biotech ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVan Eck Fund NameVanEck Biotech ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:BBH Inception Date12/20/2011 Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMarket Vectors US Listed Biotech 25 Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionGlobal Number of Holdings26 Fund Statistics Assets Under Management$442.06 million Average Daily Volume$7,992.50 Discount/Premium0.02% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianState Street Bank and Trust Company DistributorVan Eck Securities Corporation Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest2,100 shs Miscellaneous Outstanding Shares2,650,000Beta0.76 Creation Unit50,000 Creation Fee$500.00 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit VanEck Biotech ETF ExpensesTypeBBHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.35%0.56%0.54%0.48%0.51%Other Expenses0.00%0.40%0.54%0.34%0.58%Total Expense0.35%0.72%0.70%0.58%0.70%Fee Waiver0.00%-0.53%-0.55%-0.22%-0.56%Net Expense0.35%0.60%0.60%0.54%0.58% VanEck Biotech ETF (BBH) Holdings & ExposureTop 10 BBH HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 15.02%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 9.32%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 7.81%Gilead Sciences(NASDAQ:GILD)Holding Weight: 7.45%Moderna(NASDAQ:MRNA)Holding Weight: 6.54%argenx(NASDAQ:ARGX)Holding Weight: 4.57%Biogen(NASDAQ:BIIB)Holding Weight: 4.51%IQVIA(NYSE:IQV)Holding Weight: 4.49%Illumina(NASDAQ:ILMN)Holding Weight: 4.17%ICON Public(NASDAQ:ICLR)Holding Weight: 4.13%BBH Sector ExposureBBH Industry ExposureFull Holdings Details Similar ETFsVanEck Pharmaceutical ETFNASDAQ:PPHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco Dorsey Wright Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBPrincipal Healthcare Innovators ETFNASDAQ:BTECInstitutional OwnershipWilliams Jones Wealth Management LLC.Sold 210 shares on 5/8/2024Ownership: 0.083%Valley Wealth Managers Inc.Bought 2,146 shares on 5/4/2024Ownership: 0.729%Conservest Capital Advisors Inc.Sold 670 shares on 5/2/2024Ownership: 0.715%Janney Montgomery Scott LLCSold 150 shares on 5/1/2024Ownership: 0.161%Commonwealth Equity Services LLCBought 340 shares on 4/29/2024Ownership: 1.127%View All Institutional Transactions BBH ETF - Frequently Asked Questions How have BBH shares performed in 2024? VanEck Biotech ETF's stock was trading at $165.31 on January 1st, 2024. Since then, BBH shares have increased by 2.0% and is now trading at $168.54. View the best growth stocks for 2024 here. How often does VanEck Biotech ETF pay dividends? What is the dividend yield for VanEck Biotech ETF? VanEck Biotech ETF declared an annual dividend on Friday, December 15th. Shareholders of record on Tuesday, December 19th will be paid a dividend of $0.7127 per share on Friday, December 22nd. The ex-dividend date is Monday, December 18th. Read our dividend analysis for BBH. What does BBH invest in? VanEck Biotech ETF is a equity fund issued by Van Eck. BBH focuses on health care investments and follows the Market Vectors US Listed Biotech 25 Index. The fund's investments total to approximately $442.06 million assets under management. What stocks does VanEck Biotech ETF hold? BBH invests in 26 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Gilead Sciences (GILD), Moderna (MRNA), argenx (ARGX), Biogen (BIIB), IQVIA (IQV), Illumina (ILMN) and ICON Public (ICLR). What is the management fee for VanEck Biotech ETF? VanEck Biotech ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for BBH is 0.35%. What other stocks do shareholders of VanEck Biotech ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), Novavax (NVAX). Who are VanEck Biotech ETF's major shareholders? VanEck Biotech ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Commonwealth Equity Services LLC (1.13%), Valley Wealth Managers Inc. (0.73%), Conservest Capital Advisors Inc. (0.72%), Altfest L J & Co. Inc. (0.29%), Aspiriant LLC (0.16%) and Janney Montgomery Scott LLC (0.16%). How do I buy shares of VanEck Biotech ETF? Shares of BBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BBH) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldWhy Is Gold On a MASSIVE rally? Huge AlertsUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate Capital348 million Americans lives to END as we know it?The Oxford ClubBiden Nomination CANCELED?The Freeport SocietyGold Set to EXPLODE!Gold Safe ExchangeDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.